NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to ...

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

Sana Biotechnology Inc. concealed from investors that it was running low on money to continuing developing drug candidates ...

NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 11.16%, which has investors questioning if this is right time to ...

Sana Biotechnology ( NASDAQ: SANA) was upgraded to Market Outperform from Market Perform at Citizens as the research broker ...

Fintel reports that on March 14, 2025, Jefferies initiated coverage of Sana Biotechnology (NasdaqGS:SANA) with a Buy ...

Corient Private Wealth LLC increased its position in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 161.7% in the fourth quarter, according to its most recent disclosure with the SEC. The ...

The latest price target for Sana Biotechnology (NASDAQ:SANA) was reported by Citizens Capital Markets on March 18, 2025. The analyst firm set a price target for $5.00 expecting SANA to rise to ...

Sana Biotechnology, Inc. announced encouraging preliminary results from a 12-week clinical study involving hypoimmune-modified pancreatic islet cells for type 1 diabetes, showing persistent C ...

Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) shares saw an uptick in trading volume on Tuesday following a better than expected earnings announcement. 3,390,446 shares traded hands ...